Scientists are testing experimental cancer therapies including mRNA therapeutic vaccines, engineered EcN bacteria that deliver romidepsin in mice, and macrophage-targeted CAR T cells.
Ralph Abraham resigned as CDC principal deputy director after less than two months, leaving the agency's top two positions vacant. The departure is part of broader HHS leadership changes under Secretary Robert F. Kennedy Jr.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07069569 |
A Multicenter Study of AHB-137 Injection Combined With Other Hepatitis B Drugs |
RECRUITING | PHASE2 |
